<div id="readability-page-1"><p><span>Artivion (NYSE:AORT - Get Free Report)</span> was downgraded by Wall Street Zen from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research report issued on Saturday.</p><p>Several other brokerages have also recently issued reports on AORT. Stifel Nicolaus lifted their target price on shares of Artivion from $40.00 to $46.00 and gave the stock a &#34;buy&#34; rating in a report on Monday, September 29th. Canaccord Genuity Group raised their price target on shares of Artivion from $50.00 to $51.00 and gave the company a &#34;buy&#34; rating in a research report on Friday, November 7th. Needham &amp; Company LLC boosted their price objective on shares of Artivion from $50.00 to $58.00 and gave the stock a &#34;buy&#34; rating in a report on Friday, November 7th. Citizens Jmp increased their target price on Artivion from $47.00 to $53.00 and gave the company a &#34;market outperform&#34; rating in a research note on Friday, November 7th. Finally, Oppenheimer  restated an &#34;outperform&#34; rating and issued a $50.00 price target on shares of Artivion in a research note on Friday, November 7th. Seven equities research analysts have rated the stock with a Buy rating, one  has issued  a Hold rating and one  has assigned  a Sell rating to the company. Based on data from MarketBeat, Artivion currently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $49.11.</p><p><b>View Our Latest Report on Artivion</b></p><h2>Artivion Trading Down 0.7%</h2><p>Artivion stock opened at $45.16 on Friday. Artivion has a 12 month low of $21.97 and a 12 month high of $48.04. The company has a market capitalization of $2.14 billion, a price-to-earnings ratio of -188.17 and a beta of 1.60. The business's fifty day simple moving average is $44.34 and its two-hundred day simple moving average is $38.65. The company has a current ratio of 3.93, a quick ratio of 2.88 and a debt-to-equity ratio of 0.50. </p><p>Artivion (NYSE:AORT - Get Free Report) last posted its quarterly earnings results on Thursday, November 6th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.02. Artivion had a positive return on equity of 5.98% and a negative net margin of 2.16%.The firm had revenue of $113.39 million during the quarter, compared to analyst estimates of $110.71 million. The company's quarterly revenue was up 18.9% on a year-over-year basis.  As a group, equities analysts predict that  Artivion will post 0.37 earnings per share for the current fiscal year. </p><h2>Insider Buying and Selling at Artivion</h2><p>In other news, Director Elizabeth A. Hoff sold 4,200 shares of the stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $45.10, for a total transaction of $189,420.00. Following the transaction, the director directly owned 27,189 shares of the company's stock, valued at $1,226,223.90. This represents a 13.38% decrease in their position. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is available through this link. Also, SVP Jean F. Holloway sold 7,315 shares of Artivion stock in a transaction on Wednesday, December 3rd. The stock was sold at an average price of $45.30, for a total value of $331,369.50. Following the completion of the sale, the senior vice president directly owned 156,093 shares of the company's stock, valued at $7,071,012.90. The trade was a 4.48% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 234,511 shares of company stock worth $10,612,452. 7.60% of the stock is owned by corporate insiders. </p><h2>Hedge Funds Weigh In On Artivion</h2><p>Several institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. boosted its holdings in shares of  Artivion by 8.3% in the third quarter. Vanguard Group Inc. now owns 3,029,059 shares of the company's stock worth $128,250,000 after buying an additional 232,424 shares during the last quarter.  Wellington Management Group LLP raised its position in  Artivion by 4.1% in the first quarter. Wellington Management Group LLP now owns 1,727,408 shares of the company's stock worth $42,460,000 after acquiring an additional 67,327 shares during the period.  Next Century Growth Investors LLC raised its position in  Artivion by 107.6% in the first quarter. Next Century Growth Investors LLC now owns 1,022,775 shares of the company's stock worth $25,140,000 after acquiring an additional 530,122 shares during the period.  Bank of America Corp DE boosted its stake in shares of  Artivion by 22.8% during the 2nd quarter. Bank of America Corp DE now owns 645,070 shares of the company's stock worth $20,062,000 after acquiring an additional 119,634 shares during the last quarter.  Finally, Invesco Ltd. grew its position in shares of  Artivion by 40.8% during the 2nd quarter. Invesco Ltd. now owns 481,026 shares of the company's stock valued at $14,960,000 after acquiring an additional 139,370 shares during the period. Institutional investors own  86.37% of the company's stock. </p><h2>About Artivion</h2> (Get Free Report)<p>Artivion, Inc manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Artivion</li><li>What Does Downgrade Mean in Investing?</li><li>Synopsys Sees Bullish Shift as Ansys Integration Drives Growth</li><li>How to Use the MarketBeat Stock Screener </li><li>The Best Holiday Present You Can Give Yourself? Costco Stock</li><li>3 Grocery Stocks That Can Help Take a Bite Out of Inflation </li><li>Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFPUlQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFPUlQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Artivion Right Now?</h2><p>Before you consider Artivion, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Artivion wasn't on the list.</p><p>While Artivion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

AORT

<p>Wall Street Zen downgraded Artivion (NYSE:AORT) from a "strong-buy" rating to a "buy" rating. Other brokerages, including Stifel Nicolaus, Canaccord Genuity Group, Needham & Company LLC, Citizens Jmp, and Oppenheimer, have maintained or raised their price targets and buy ratings for Artivion. The company reported positive earnings and revenue growth. Insiders have sold shares recently, and several institutional investors have increased their positions in the company.</p>

Artivion (NYSE:AORT) Cut to "Buy" at Wall Street Zen